Clinical Calibration & Validation of a Next-Generation Blood Pressure Monitor for Patient Management (CCV)
Comparison, Calibration, and Validation of the Non-invasive Cloud DX Pulsewave Health MonitorTM With Direct Invasive Radial and Central Arterial Measurements During Cardiac Catheterization
Sponsor: Cardiovascular Research New Brunswick
This observational or N/A phase trial investigates Hypertension and is currently completed. Cardiovascular Research New Brunswick leads this study, which shows 12 recorded versions since 2013 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Sep 2021 — Dec 2021 [monthly]
Completed
Status: Unknown Status → Completed
▶ Show 7 earlier versions
-
Jan 2021 — Sep 2021 [monthly]
Unknown Status
-
Mar 2020 — Jan 2021 [monthly]
Unknown Status
Status: Active Not Recruiting → Unknown Status
-
Aug 2018 — Mar 2020 [monthly]
Active Not Recruiting
-
Jun 2018 — Aug 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Mar 2018 — Apr 2018 [monthly]
Active Not Recruiting NA
-
Feb 2017 — Mar 2018 [monthly]
Active Not Recruiting NA
First recorded
Nov 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cardiovascular Research New Brunswick
- Cloud DX Inc.
- Dalhousie University
- Horizon Health Network
- New Brunswick Health Research Foundation
For direct contact, visit the study record on ClinicalTrials.gov .